From Surf Wiki (app.surf) — the open knowledge base

Pliva

Croatian pharmaceutical company

Field	Value
name	Pliva d.o.o.
logo	PLIVA Logo.svg
type	Subsidiary
industry	Pharmaceutical industry
parent	Teva Pharmaceuticals
foundation
location	Zagreb, Croatia
key_people	Mihael Furjan (CEO)
num_employees	1,700
products	Generic drugs
revenue	$1.174 billion (2005)
net_income	$0.336 billion (2005)
homepage
footnotes

Note

the Croatian company

Azithromycin, also known as Sumamed, is one of the world's best-selling antibiotics.

Pliva d.o.o. is a pharmaceutical company based in Zagreb, Croatia that primarily manufactures and sells generic drugs. It is a subsidiary of Teva Pharmaceuticals.

Pliva is one of the world's largest producers of generic Adderall.

History

In 1918 Gustav Janeček founded the wholesale drug company Isis (today Medika). In 1921 he co-founded the pharmaceutical factory Kaštel d.d. in Karlovac as a joint venture with Isis and Budapest-based Chinoin, and served as the company's first president of the board. The company kept its name after moving production to Zagreb in 1927. It was only in 1941 that it was renamed PLIVA as an acronym for the State Institute for Production of Medicines and Vaccines.

A team of Pliva's researchers, Gabrijela Kobrehel, Gorjana Radobolja-Lazarevski and Zrinka Tamburašev led by Dr. Slobodan Đokić, discovered azithromycin in 1980.

In June 2002, the company acquired Sidmak for $152.9 million.

Also in June 2002, Zeljko Peric, the chief financial officer of the company, resigned.

In May 2004, the company received approval from the Food and Drug Administration to sell trospium chloride.

In June 2005, the company received approval to sell a generic version of erythropoietin in Croatia.

In November 2005, the company received approval from the Food and Drug Administration to sell a generic version of Azithromycin, Citalopram, and Ondansetron.

In October 2006, Barr Pharmaceuticals acquired Pliva.

On December 23, 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceuticals and the company became part of Teva Active Pharmaceutical Ingredients (TAPI).

References

"Company Profile". Pliva.
"JANEČEK, Gustav".
Snježana Bičak. (1 October 2018). "Preteča Plive osnovana je u starom dvorcu u Karlovcu 1921.". Večernji list.
Inić, S.. (2021). "Adolf Thierry and the first pharmaceutical factory in Croatia". Pharmazie.
"PLIVA d.d.".
(11 May 2017). "Dionice tvrtke Kaštel, iz koje je kasnije nastala Pliva, oduzete su njegovom djedu krajem 2. svjetskog rata...". Jutarnji list.
Mutak, Stjepan. (2007). "Azalides from Azithromycin to New Azalide Derivatives". The Journal of Antibiotics.
(June 11, 2002). "PLIVA announces acquisition of US-based Sidmak". Pliva.
(June 27, 2002). "PLIVA announces management changes". Pliva.
(May 31, 2004). "PLIVA Announces FDA Approval of SANCTURA". Pliva.
(June 21, 2005). "PLIVA Registers generic EPO in Croatia". Pliva.
(November 15, 2005). "PLIVA Announces Approval for Azithromycin Tablets". Pliva.
(November 3, 2005). "PLIVA Announces Approval for Citalopram Hydrobromide Tablets". Pliva.
(November 21, 2005). "PLIVA Announces Approval for Ondansetron Hydrochloride ODT". Pliva.
(October 12, 2006). "Barr Acquires PLIVA d.d.". Pliva.
(December 23, 2008). "TEVA COMPLETES ACQUISITION OF BARR". Pliva.

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

1921-establishments-in-croatia manufacturing-companies-based-in-zagreb croatian-brands pharmaceutical-companies-established-in-1921 pharmaceutical-companies-of-croatia 2006-mergers-and-acquisitions

Want to explore this topic further?

Ask Mako anything about Pliva — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report